122 related articles for article (PubMed ID: 38733125)
21. An institutional experience with DICER1 mutated thyroid nodules-evaluating the cytomorphology and molecular phenotype.
Lee SH; Vadlamudi C; Zhao Q; Yilmaz O; Cerda S
J Am Soc Cytopathol; 2022; 11(6):335-344. PubMed ID: 35934646
[TBL] [Abstract][Full Text] [Related]
22. Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma /
Brenneman M; Field A; Yang J; Williams G; Doros L; Rossi C; Schultz KA; Rosenberg A; Ivanovich J; Turner J; Gordish-Dressman H; Stewart D; Yu W; Harris A; Schoettler P; Goodfellow P; Dehner L; Messinger Y; Hill DA
F1000Res; 2015; 4():214. PubMed ID: 26925222
[TBL] [Abstract][Full Text] [Related]
23. Embryonal rhabdomyosarcoma in a patient with a heterozygous frameshift variant in the DICER1 gene and additional manifestations of the DICER1 syndrome.
Fremerey J; Balzer S; Brozou T; Schaper J; Borkhardt A; Kuhlen M
Fam Cancer; 2017 Jul; 16(3):401-405. PubMed ID: 27896549
[TBL] [Abstract][Full Text] [Related]
24. Sertoli-Leydig cell tumor associated with a germline
Wang JY; Ma KK; Reiter DJ; Torvie A; Swisher EM
Gynecol Oncol Rep; 2023 Aug; 48():101215. PubMed ID: 37334322
[TBL] [Abstract][Full Text] [Related]
25. A novel DMD intronic alteration: a potentially disease-causing variant of an intermediate muscular dystrophy phenotype.
Santin R; Vieira IA; Nunes JC; Benevides ML; Quadros F; Brusius-Facchin AC; Macedo G; Bertoni APS
Acta Myol; 2021 Jun; 40(2):93-100. PubMed ID: 34355126
[TBL] [Abstract][Full Text] [Related]
26. Cryptic exon activation caused by a novel deep-intronic splice-altering variant in Becker muscular dystrophy.
Xie Z; Lu Y; Liu C; Sun C; Yu J; Ling C; Luan X; Wang W; Wang L; Liang Y; Luo Q; Meng L; Wang Z; Yuan Y
J Clin Lab Anal; 2023 Nov; 37(21-22):e24987. PubMed ID: 37968799
[TBL] [Abstract][Full Text] [Related]
27. DICER1 Syndrome: Characterization of the Ocular Phenotype in a Family-Based Cohort Study.
Huryn LA; Turriff A; Harney LA; Carr AG; Chevez-Barrios P; Gombos DS; Ram R; Hufnagel RB; Hill DA; Zein WM; Schultz KAP; Bishop R; Stewart DR
Ophthalmology; 2019 Feb; 126(2):296-304. PubMed ID: 30339877
[TBL] [Abstract][Full Text] [Related]
28. Predominant
Lee YA; Im SW; Jung KC; Chung EJ; Shin CH; Kim JI; Park YJ
Thyroid; 2020 Aug; 30(8):1120-1131. PubMed ID: 32228164
[No Abstract] [Full Text] [Related]
29. An Unusual Enteric Yolk Sac Tumor: First Report of an Ovarian Germ Cell Tumor Associated With a Germline Pathogenic Variant in DICER1.
McCluggage WG; Fu L; Mohler K; de Kock L; Sabbaghian N; Mindlin A; Stewart CJR; Gilks CB; Foulkes WD
Int J Gynecol Pathol; 2022 Jul; 41(4):349-355. PubMed ID: 34380971
[TBL] [Abstract][Full Text] [Related]
30. Genome sequencing-based discovery of a novel deep intronic APC pathogenic variant causing exonization.
Bozsik A; Butz H; Grolmusz VK; Polgár C; Patócs A; Papp J
Eur J Hum Genet; 2023 Jul; 31(7):841-845. PubMed ID: 36828923
[TBL] [Abstract][Full Text] [Related]
31. Germline and somatic DICER1 mutations in a pituitary blastoma causing infantile-onset Cushing's disease.
Sahakitrungruang T; Srichomthong C; Pornkunwilai S; Amornfa J; Shuangshoti S; Kulawonganunchai S; Suphapeetiporn K; Shotelersuk V
J Clin Endocrinol Metab; 2014 Aug; 99(8):E1487-92. PubMed ID: 24823459
[TBL] [Abstract][Full Text] [Related]
32. Exploring the association Between DICER1 mutations and differentiated thyroid carcinoma.
de Kock L; Sabbaghian N; Soglio DB; Guillerman RP; Park BK; Chami R; Deal CL; Priest JR; Foulkes WD
J Clin Endocrinol Metab; 2014 Jun; 99(6):E1072-7. PubMed ID: 24617712
[TBL] [Abstract][Full Text] [Related]
33. Identification of splice defects due to noncanonical splice site or deep-intronic variants in ABCA4.
Fadaie Z; Khan M; Del Pozo-Valero M; Cornelis SS; Ayuso C; Cremers FPM; Roosing S; The Abca Study Group
Hum Mutat; 2019 Dec; 40(12):2365-2376. PubMed ID: 31397521
[TBL] [Abstract][Full Text] [Related]
34. Clinical heterogeneity and reduced penetrance in DICER1 syndrome: a report of three families.
Azzollini J; Ferrari A; Stracuzzi A; Chiaravalli S; Terenziani M; Spreafico F; Grasso M; Collini P; Pensotti V; Massimino M; Arbustini E; Manoukian S
Tumori; 2021 Dec; 107(6):NP144-NP148. PubMed ID: 34761719
[TBL] [Abstract][Full Text] [Related]
35. Rare Germline
Martínez de LaPiscina I; Hernández-Ramírez LC; Portillo N; Gómez-Gila AL; Urrutia I; Martínez-Salazar R; García-Castaño A; Aguayo A; Rica I; Gaztambide S; Faucz FR; Keil MF; Lodish MB; Quezado M; Pankratz N; Chittiboina P; Lane J; Kay DM; Mills JL; Castaño L; Stratakis CA
Front Endocrinol (Lausanne); 2020; 11():433. PubMed ID: 32714280
[No Abstract] [Full Text] [Related]
36. Neoplasm Risk Among Individuals With a Pathogenic Germline Variant in DICER1.
Stewart DR; Best AF; Williams GM; Harney LA; Carr AG; Harris AK; Kratz CP; Dehner LP; Messinger YH; Rosenberg PS; Hill DA; Schultz KAP
J Clin Oncol; 2019 Mar; 37(8):668-676. PubMed ID: 30715996
[TBL] [Abstract][Full Text] [Related]
37. Clinical Characteristics of
Weisschuh N; Mazzola P; Bertrand M; Haack TB; Wissinger B; Kohl S; Stingl K
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065499
[TBL] [Abstract][Full Text] [Related]
38. Hodgkin lymphoma as a novel presentation of familial DICER1 syndrome.
Kuhlen M; Hönscheid A; Schemme J; Merz H; Mauz-Körholz C; Borkhardt A; Troeger A
Eur J Pediatr; 2016 Apr; 175(4):593-7. PubMed ID: 26526666
[TBL] [Abstract][Full Text] [Related]
39. Recurrent gynandroblastoma of the ovary with germline
Mercier AM; Zorn KK; Quick CM; Huffman LB
Gynecol Oncol Rep; 2021 Aug; 37():100806. PubMed ID: 34169133
[TBL] [Abstract][Full Text] [Related]
40. Unusual phenotypes in patients with a pathogenic germline variant in DICER1.
Venger K; Elbracht M; Carlens J; Deutz P; Zeppernick F; Lassay L; Kratz C; Zenker M; Kim J; Stewart DR; Wieland I; Schultz KAP; Schwerk N; Kurth I; Kontny U
Fam Cancer; 2023 Oct; 22(4):475-480. PubMed ID: 34331184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
